BH Childs

2.5k citations

20 papers · 1.9k indexed · 2 hit papers · h-index 11

Impact in

Hematology top 1%
- Hematopoietic Stem Cell Transplantation
Immunology top 5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses

Papers in

Transplantation 2
- Renal Transplantation Outcomes and Treatments 2
Hematology 6
- Hematopoietic Stem Cell Transplantation 3
- Chronic Myeloid Leukemia Treatments 2

Co-authors: Terri H. Beaty Gary D. Steinberg P C Walsh Farid Boulad Hugo Castro‐Malaspina Stephen Mackinnon AP Gillio NA Kernan
Journals: Blood (5 papers)Cancer Research (3 papers)Journal of Clinical Oncology (2 papers)Bone Marrow Transplantation (1 paper)Leukemia Research (1 paper)
Partner nations: United States South Africa Germany

In The Last Decade

BH Childs

19 papers receiving 1.8k citations

Hit Papers

align trajectories log scale

Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease 1995 · 600 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1995 Blood
1992 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by BH Childs

Since Specialization

Citations

This map shows the geographic impact of BH Childs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by BH Childs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites BH Childs more than expected).

Fields of papers citing papers by BH Childs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by BH Childs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by BH Childs. The network helps show where BH Childs may publish in the future.

Co-authorship network

The 25 scholars most cited alongside BH Childs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with BH Childs Line = papers co-authored together BH Childs links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer Zeitschrift für Gastroenterologie ·Serge Leyvraz, Jordan Berlin, Tricia Harkin, John F. Deeken, Valentina Boni, D-Y. Oh, Jyoti D. Patel, Shivani Nanda, Nicoletta Brega, BH Childs, Annefien Tiggeler, Alexander Drilon	2020	0
2	372 Safety and activity of the anti-mesothelin antibody–drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian, fallopian tube or primary peritoneal cancer Alessandro D. Santin, Ignace Vergote, Antonio González-Martı́n, Kathleen N. Moore, Ana Oaknin, Ignacio Romero, Sami Diab, L. Copeland, Bradley J. Monk, RE Coleman, Guo Hailian, Jonathan Siegel, Annette O. Walter, BH Childs, Cem Elbi, Iurie Bulat	2020	4
3	Abstract P6-12-08: Phase II Multicenter Study of Docetaxel and Bevacizumab (Bev) +/− Trastuzumab as First-Line Treatment of Patients with Metastatic Breast Cancer (MBC) Cancer Research ·Shuki Inoue, Róbert Hermann, Johnetta Blakely, Yogendra Nath Mann, Maedeh Sadat Tahaei, BH Childs	2010	2
4	GRB7-dependent pathways are potential therapeutic targets in triple-negative breast cancer. Cancer Research ·貴志三谷, Robert P. Gray, LJ Goldstein, BH Childs, Roberto Bugarini, Simone M. Rowley, Jennifer H.E. Baker, S. Shak, S Badve, Usha Sood, EA Perez, L. Shulman, Sabata Martino, Katherine Corbett, NE Davidson	2009	3
5	Preliminary safety results: addition of bevacizumab to 3 docetaxel regimens as adjuvant therapy for early stage breast cancer. Cancer Research ·DA Yardley, Y N Liu, Rachel Nolan, Suprith Badarinath, 小田九二夫, David Cook, John Thompson, BH Childs, Sonja Buchleitner	2009	8
6	Preliminary results of a phase II study of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube Journal of Clinical Oncology ·Peter G. Rose, Richard D. Drake, Patricia S. Braly, Maria C. Bell, Robert M. Wenham, Serena Montalbano, A. Alvarez-Secord, Kuang-Jung Hsu, BH Childs, Guo Hailian	2009	17
7	The Impact of Conversion From Mycophenolate Mofetil to Mycophenolate Sodium Among Renal Transplant Recipients on a Sirolimus-Based Regimen Transplantation Proceedings ·B D Kahan, Jeanette M. Podbielski, BH Childs	2008	3
8	Preliminary safety and efficacy results of a phase II study of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube Journal of Clinical Oncology ·Thomas J. Herzog, Nicola M. Spirtos, Jeffrey F. Hines, Patricia S. Braly, Maria C. Bell, Angeles Alvarez Secord, Peter G. Rose, B.J. Monk, Kuang-Jung Hsu, BH Childs	2007	2
9	RIP kinase is involved in arsenic-induced apoptosis in multiple myeloma cells APOPTOSIS ·Olga Bajenova, Baiqing Tang, Roger Pearse, Rena Feinman, BH Childs, Joseph Michaeli	2004	13
10	Dynamics of hematopoiesis in paroxysmal nocturnal hemoglobinuria (PNH): no evidence for intrinsic growth advantage of PNH clones Leukemia ·V. Mathieu, Monica Bessler, Susan McKenzie, Hugo Castro‐Malaspina, BH Childs, Farid Boulad, Anastasios Karadimitris, Rosario Notaro, Lucio Luzzatto	2002	40
11	Comparison of Immune Reconstitution After Unrelated and Related T-Cell–Depleted Bone Marrow Transplantation: Effect of Patient Age and Donor Leukocyte Infusions Blood ·TN Small, Esperanza B. Papadopoulos, Farid Boulad, P Black, Hugo Castro‐Malaspina, BH Childs, N H Collins, AP Gillio, Diane George, Ann A. Jakubowski, Glenn Heller, Melissa Fazzari, Nancy A. Kernan, Stephen Mackinnon, Paul Szabolcs, James W. Young, R.J. O’Reilly	1999	384
12	Comparison of Immune Reconstitution After Unrelated and Related T-Cell–Depleted Bone Marrow Transplantation: Effect of Patient Age and Donor Leukocyte Infusions Blood ·TN Small, Esperanza B. Papadopoulos, Farid Boulad, P Black, Hugo Castro‐Malaspina, BH Childs, N H Collins, AP Gillio, Diane George, Ann A. Jakubowski, Glenn Heller, Melissa Fazzari, Nancy A. Kernan, Stephen Mackinnon, Paul Szabolcs, James W. Young, R.J. O’Reilly	1999	35
13	Differential growth patterns in SCID mice of patient-derived chronic myelogenous leukemias Bone Marrow Transplantation ·Joseph P. McGuirk, 篤穂前田, BH Childs, José M. Fernández, L Barnett, Yuan Zhang-bi, Sophie Seys, RJ O’Reilly	1998	24
14	Antileukemia activity of a natural killer cell line against human leukemias. PubMed ·篤穂前田, Peter G. Steinherz, Hans Klingemann, Dieter Dennig, BH Childs, Joseph P. McGuirk, R.J. O’Reilly	1998	127
15	190 T-cell depleted (SBA-E-) bone marrow transplantation for myelodysplastic syndromes Leukemia Research ·Hugo Castro‐Malaspina, BH Childs, Evangelos Papadopoulos, Farid Boulad, Joseph Y. Young, Trudy N. Small, Nancy A. Kernan, Alejandro López Requena, Richard O’Reilly	1997	4
16	Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease Blood ·Stephen Mackinnon, Philippe Dessommes Flórez, Graham Usher, Lilian Reich, Luiz Rogério De Oliveira Hein, Farid Boulad, Hugo Castro‐Malaspina, BH Childs, AP Gillio, NA Kernan Hit paper breakdown →	1995	600
17	Marrow transplantation from hepatitis C virus seropositive donors: transmission rate and clinical course Blood ·S. Bielecki, David Myerson, BH Childs, Michael S. Morkos, Jazil Tamang, DS Snyder, DerPunkt, Z Kayzer, GB McDonald	1994	40
18	Marrow transplantation from hepatitis C virus seropositive donors: transmission rate and clinical course Blood ·S. Bielecki, David Myerson, BH Childs, Michael S. Morkos, Jazil Tamang, DS Snyder, DerPunkt, Z Kayzer, GB McDonald	1994	4
19	Mendelian inheritance of familial prostate cancer. Proceedings of the National Academy of Sciences ·Zeliha Hekimsoy, Terri H. Beaty, Gary D. Steinberg, BH Childs, P C Walsh Hit paper breakdown →	1992	518
20	Familial risk factors for prostate cancer. PubMed ·Cristina Mello França, Garth Harris, 聡枝藤岡, BH Childs, Walsh Pc	1991	28

About BH Childs

BH Childs is a scholar working on Transplantation, Hematology, Reproductive Medicine, Oncology and Hepatology, having authored 20 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Immune Cell Function and Interaction (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Hematopoietic Stem Cell Transplantation (3 papers), Renal Transplantation Outcomes and Treatments (2 papers), Intraperitoneal and Appendiceal Malignancies (2 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Retinoids in leukemia and cellular processes (2 papers). The work is most often cited by research in Hematology (883 citations), Immunology (767 citations), Transplantation (56 citations), Oncology (500 citations) and Pulmonary and Respiratory Medicine (414 citations). BH Childs has collaborated with scholars based in United States, South Africa and Germany. Frequent co-authors include Terri H. Beaty, Gary D. Steinberg, P C Walsh, Farid Boulad, Hugo Castro‐Malaspina, Stephen Mackinnon, AP Gillio, NA Kernan, Lilian Reich and R.J. O’Reilly. Their work appears in journals such as Blood, Cancer Research, Journal of Clinical Oncology, Bone Marrow Transplantation and Leukemia Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact